Extracellular matrix gene regulation

Clinical Orthopaedics and Related Research

Volumn 427, Issue SUPPL., 2004, Pages

  Okazaki, Ken ^a   Sandell, Linda J ^a,b  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; PROTEIN CD RAP; PROTEIN COL11A2; PROTEIN COL2A1; PROTEIN COL9A2; PROTEIN CYRBP1; PROTEIN DELTA EF1; PROTEIN NT2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SLUG; UNCLASSIFIED DRUG;

ARTHRITIS; BONE DEVELOPMENT; BONE REMODELING; CARTILAGE; CARTILAGE CELL; CELL METABOLISM; CHONDROGENESIS; CIS ISOMER; CONFERENCE PAPER; EXTRACELLULAR MATRIX; FRACTURE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC REGULATION; GENETIC TRANSCRIPTION; NONHUMAN; OSTEOTOMY; PRIORITY JOURNAL; RNA SYNTHESIS; SKELETAL MUSCLE;

EID: 5444227494     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000144478.51284.f3     Document Type: Conference Paper

References (45)

1. Aigner T, Zien A, Hanisch D, Zimmer R: Gene expression in chondrocytes assessed with use of microarrays. J Bone Joint Surg 85-A(Suppl 2):117-123, 2003.
2. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B: Sox9 is required for cartilage formation. Nat Genet 22:85-89, 1999.
3. Bosserhoff AK, Kondo S, Moser M, et al: Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma. Dev Dyn 208:516-525, 1997.
4. Bridgewater LC, Lefebvre V, de Crombrugghe B: Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem 273:14998-15006, 1998.
5. Cui CB, Cooper LF, Yang X, Karsenty G, Aukhil I: Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol Cell Biol 23:1004-1013, 2003.
6. Davies SR, Li J, Okazaki K, Sandell LJ: Tissue-restricted expression of the Cdrap/Mia gene within a conserved multigenic housekeeping locus. Genomics 83:667-678, 2004.
7. Dietz UH, Sandell LJ: Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J Biol Chem 271:3311-3316, 1996.
8. Ducy P, Karsenty G: Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869, 1995.
9. Fernandez-Lloris R, Vinals F, Lopez-Rovira T, et al: Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells. Mol Endocrinol 17:1332-1343, 2003.
10. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ: Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg 85-A(Suppl 3):59-66, 2003.
11. Gutierrez S, Javed A, Tennant DK, et al: CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem 277:1316-1323, 2002.
12. Huang W, Zhou X, Lefebvre V, de Crombrugghe B: Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol 20:4149-4158, 2000.
13. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B: The chondrogenic transcription factor Sox9 is a target of signalling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 98:160-165, 2001.
14. Huang Z, Xu H, Sandell L: Negative regulation of chondrocyte differentiation by transcription factor AP-2alpha. J Bone Miner Res 19:245-255, 2004.
15. Ito Y: Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF. Genes Cells 4:685-696, 1999.
16. Javed A, Barnes GL, Jasanya BO, et al: runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: Evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol 21:2891-2905, 2001.
17. Jeon MJ, Kim JA, Kwon SH, et al: Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem 278:23270-23277, 2003.
18. Jimenez MJ, Balbin M, Lopez JM, et al: Collagenase 3 is a target of Cbfal, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19:4431-4442, 1999.
19. Komori T, Yagi H, Nomura S, et al: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764, 1997.
20. Krebsbach PH, Nakata K, Bernier SM, et al: Identification of a minimum enhancer sequence for the type II collagen gene reveals several core sequence motifs in common with the link protein gene. J Biol Chem 271:4298-4303, 1996.
21. Lefebvre V, Zhou G, Mukhopadhyay K, et al: An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol Cell Biol 16:4512-4523, 1996.
22. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B: SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336-2346, 1997.
23. Lefebvre V, Li P, de Crombrugghe B: A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17:5718-5733, 1998.
24. Liu Y, Li H, Tanaka K, Tsumaki N, Yamada Y: Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene. J Biol Chem 275:12712-12718, 2000.
25. Mori-Akiyama Y, Akiyama H, Rowitch DH, de Crombrugghe B: Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc Natl Acad Sci USA 100:9360-9365, 2003.
26. Morrison NA, Shine J, Fragonas JC, et al: 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246:1158-1161, 1989.
27. Murakami S, Kan M, McKeehan WL, de Crombrugghe B: Upregulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 97:1113-1118, 2000.
28. Murray D, Precht P, Balakir R, Horton Jr WE: The transcription factor deltaEF1 is inversely expressed with type II collagen mRNA and can repress Col2a1 promoter activity in transfected chondrocytes. J Biol Chem 275:3610-3618, 2000.
29. Nakashima K, Zhou X, Kunkel G, et al: The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29, 2002.
30. Okazaki K, Li J, Yu H, Fukui N, Sandell LJ: CCAAT/enhancer-binding proteins beta and delta mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein induced by interleukin-1 beta. J Biol Chem 277:31526-31533, 2002.
31. Sandell LJ: a. T., D. Transcription of Bone and Cartilage Genes. Curr Opin Orthop 13:375-381, 2002.
32. Seki K, Fujimori T, Savagner P, et al: Mouse Snail family transcription repressors regulate chondrocyte extracellular matrix, type II collagen and aggrecan. J Biol Chem 12:12, 2003.
33. Sekiya I, Tsuji K, Koopman P, et al: SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 275:10738-10744, 2000.
34. Smits P, Mandel J, Zhang Z, et al: The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1:277-290, 2001.
35. Takagi T, Moribe H, Kondoh H, Higashi Y: DeltaEF1, a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages. Development 125:21-31, 1998.
36. Tanaka K, Matsumoto Y, Nakatani F, Iwamoto Y, Yamada Y: A zinc finger transcription factor, alphaA-crystallin binding protein 1, is a negative regulator of the chondrocyte-specific enhancer of the alpha1(II) collagen gene. Mol Cell Biol 20:4428-4435, 2000.
37. Tanaka K, Tsumaki N, Kozak CA, et al: A Kruppel-associated box-zinc finger protein, NT2, represses cell-type-specific promoter activity of the alpha 2(XI) collagen gene. Mol Cell Biol 22:4256-4267, 2002.
38. Tsuda M, Takahashi S, Takahashi Y, Asahara H: Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J Biol Chem 278:27224-27229, 2003.
39. Tsumaki N, Kimura T, Matsui Y, Nakata K, Ochi T: Separable cis-regulatory elements that contribute to tissue- and site-specific alpha 2(XI) collagen gene expression in the embryonic mouse cartilage. J Cell Biol 134:1573-1582, 1996.
40. Tsumaki N, Kimura T, Tanaka K, et al: Modular arrangement of cartilage- and neural tissue-specific cis-elements in the mouse alpha2(XI) collagen promoter. J Biol Chem 273:22861-22864, 1998.
41. Xie WF, Kondo S, Sandell LJ: Regulation of the mouse cartilage-derived retinoic acid-sensitive protein gene by the transcription factor AP-2. J Biol Chem 273:5026-5032, 1998.
42. Xie WF, Zhang X, Sakano S, Lefebvre V, Sandell LJ: Transactivation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res 14:757-763, 1999.
43. Xie WF, Zhang X, Sandell LJ: The 2.2-kb promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice. Matrix Biol 19:501-509, 2000.
44. Yoshida CA, Furuichi T, Fujita T, et al: Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 32:633-638, 2002.
45. Zhang P, Jimenez SA, Stokes DG: Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9. J Biol Chem 278:117-123, 2003.